Jiang, Xueyang http://orcid.org/0000-0001-9995-0484
Liu, Chang
Zou, Manxing
Xie, Huanfang
Lin, Tailiang http://orcid.org/0000-0002-3159-1355
Lyu, Weiping
Xu, Jian
Li, Yuan
Feng, Feng
Sun, Haopeng
Liu, Wenyuan
Funding for this research was provided by:
China Pharmaceutical University (CPU2018GF10, CPU2018GY34, BK20200571, 81973207)
Natural Science Foundation of Jiangsu Province (CPU2018GF10, CPU2018GY34, BK20200571, 81973207)
National Natural Science Foundation of China (CPU2018GF10, CPU2018GY34, BK20200571, 81973207)
This article is maintained by: Elsevier
Article Title: Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine
Journal Title: European Journal of Medicinal Chemistry
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ejmech.2021.113663
Content Type: article
Copyright: © 2021 Elsevier Masson SAS. All rights reserved.